Structures by: Parisi E.
Total: 10
Poly[(μ~4~-phenylphosphonato)zinc(II)]
C6H5O3PZn
IUCrData (2019) 4, 9 x191222
a=14.8549(8)Å b=5.1581(3)Å c=10.5471(6)Å
α=90° β=105.816(2)° γ=90°
4-Methyl-7-(2-pyrazinyl)-2<i>H</i>-3<i>H</i>-7<i>H</i>[1,2,4]triazolo[3,2-<i>c</i>][1,2,4]-triazolium tetrachlorozincate
2(C8H9N7)2,2(Zn1Cl4)2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 41 14452-14462
a=8.7870(17)Å b=16.250(4)Å c=41.341(7)Å
α=90° β=90° γ=90°
4-Methyl-7-(2-pyrazinyl)-2<i>H</i>-3<i>H</i>[1,2,4]triazolo[3,2-<i>c</i>][1,2,4]-triazolium chloride
(C8H8N7),(Cl)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 41 14452-14462
a=5.290(2)Å b=16.438(4)Å c=12.291(4)Å
α=90° β=107.96(2)° γ=90°
4-Methyl-7-(2-pyrazinyl)-2<i>H</i>-3<i>H</i>-7<i>H</i>[1,2,4]triazolo[3,2-<i>c</i>][1,2,4]-triazolium hexachlorostannate dihydrate
(C8H9N7)2,(Sn1Cl6)2,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 41 14452-14462
a=12.1370(19)Å b=15.2500(11)Å c=10.851(3)Å
α=90° β=90° γ=90°
Bis([4-Methyl-7-(2-pyrazinyl)-3<i>H</i>-[1,2,4]triazolo[3,2-<i>c</i>][1,2,4]-triazole k^2^-N1,N6-k^1^-N2']dichlorideZinc(II)) pentahydrate
C16H16.73Cl2.64Cu2N14O1.36,C16H14Cl4Cu2N14,1.364(Cl)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 41 14452-14462
a=10.745(2)Å b=11.371(3)Å c=12.811(2)Å
α=71.003(12)° β=76.242(15)° γ=73.412(16)°
Sodium 4-Methyl-7-(2-pyrazinyl)-[1,2,4]triazolo[3,2-<i>c</i>][1,2,4]-triazolate
(Na),(C8H6N7),3(H2O)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 41 14452-14462
a=6.8520(9)Å b=9.1940(17)Å c=10.1550(16)Å
α=72.687(18)° β=81.788(18)° γ=86.177(14)°
4-Methyl-7-(2-pyrazinyl)-2<i>H</i>-[1,2,4]triazolo[3,2-<i>c</i>][1,2,4]-triazole hydrate
(c8H7N7),(H2O)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 41 14452-14462
a=5.4070(13)Å b=8.507(3)Å c=11.507(5)Å
α=109.32(3)° β=93.16(3)° γ=96.25(3)°
Bis([4-Methyl-7-(2-pyrazinyl)-3<i>H</i>-[1,2,4]triazolo[3,2-<i>c</i>][1,2,4]-triazole k^2^-N1,N6-k^1^-N2'-triaquo-k^1^-N7-pentabromodizincate]Zinc(II)) dihydrate
C16H26Br12N14O6Zn6,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 41 14452-14462
a=9.282(3)Å b=10.500(9)Å c=13.206(12)Å
α=107.35(7)° β=90.60(6)° γ=101.75(4)°
2(C32H45N5O8),C2HF3O2,4(CH4O),2(H2O)
2(C32H45N5O8),C2HF3O2,4(CH4O),2(H2O)
Chemical communications (Cambridge, England) (2020) 56, 20 3015-3018
a=9.5290(19)Å b=23.743(5)Å c=18.276(4)Å
α=90° β=96.35(3)° γ=90°
3-(3-Hydroxyphenyl)-6-methyl-1<i>H</i>-[1,2,4]triazolo[3,2-<i>c</i>][1,2,4]triazole
C10H9N5O
Acta Crystallographica Section C (2019) 75, 10 1398-1404
a=12.251(5)Å b=7.457(3)Å c=20.863(6)Å
α=90° β=90° γ=90°